Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04

AUTHORS

I. Blancas, E. Aguirre, S. Morales, M. L. Gonzálvez, S. Servitja, N. Díaz, S. del Barco, A. Barnadas, M. Margelí, I. García Carbonero, A. Llombart

ABSTRACT

PURPOSE: To evaluate the efficacy and safety of oral weekly vinorelbine 60 mg/m2 for metastatic breast cancer (MBC) in patients previously treated with anthracyclines or taxanes in routine clinical practice. MATERIALS AND METHODS: Fifty-five patients were enrolled in a prospective multicentre study conducted in Spain. Women ≥ 18 years of age with locally advanced breast cancer who were not candidates for surgical treatment with a radical intention or patients with stage IV disease, and who had received a prior taxane or anthracycline regimen were eligible for participation. RESULTS: Median age was 67 years. Median progression-free survival was 3.7 months (95% CI 2.5-4.9), median overall survival 10 months (95% CI 6.6-13.5), and overall response rate and clinical benefit rate were 29.1% and 49.1%, respectively. Main grade 3 and 4 toxicities were neutropenia 9.1%, febrile neutropenia 3.6% and constipation 3.6%. In total, 86% of the patients received complete treatment without delays or dose reduction. Moreover, HER2-positive patients who received oral vinorelbine concomitantly with trastuzumab showed better response (complete response: HER2-positive 14.3% vs. HER2-negative 0%; partial response: HER2-positive 42.9% vs. HER2-negative 25.6%; p = 0.008), better disease control rate (HER2-positive 100% vs. HER2-negative 46.2%; p = 0.011), and better values for the remaining analysed variables than HER2-negative patients. CONCLUSION: Our study provides real-world data on the use of oral weekly vinorelbine, which proves an effective and well-tolerated regimen for MBC patients previously treated with taxanes or anthracyclines. Patients with HER2-positive disease could also benefit from this treatment in combination with trastuzumab. More... »

PAGES

459-466

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12094-018-1946-9

DOI

http://dx.doi.org/10.1007/s12094-018-1946-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1107436870

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30293232


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Complejo Hospitalario Universitario de Granada", 
          "id": "https://www.grid.ac/institutes/grid.459499.c", 
          "name": [
            "Department of Medical Oncology, University Hospital San Cecilio, Av. De la Investigaci\u00f3n s/n, 18016, Granada, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Blancas", 
        "givenName": "I.", 
        "id": "sg:person.0651022236.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651022236.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitari Arnau de Vilanova", 
          "id": "https://www.grid.ac/institutes/grid.411443.7", 
          "name": [
            "Department of Medical Oncology, University Hospital Arnau de Vilanova, Lleida, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aguirre", 
        "givenName": "E.", 
        "id": "sg:person.01132141013.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132141013.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitari Arnau de Vilanova", 
          "id": "https://www.grid.ac/institutes/grid.411443.7", 
          "name": [
            "Department of Medical Oncology, University Hospital Arnau de Vilanova, Lleida, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morales", 
        "givenName": "S.", 
        "id": "sg:person.01152225642.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152225642.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Oncology, University Hospital Arrixaca, Murcia, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gonz\u00e1lvez", 
        "givenName": "M. L.", 
        "id": "sg:person.012652353747.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012652353747.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Del Mar", 
          "id": "https://www.grid.ac/institutes/grid.411142.3", 
          "name": [
            "Department of Medical Oncology, Hospital Del Mar, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Servitja", 
        "givenName": "S.", 
        "id": "sg:person.0603672146.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603672146.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitari Sant Joan D'Alacant", 
          "id": "https://www.grid.ac/institutes/grid.411263.3", 
          "name": [
            "Department of Medical Oncology, University Hospital San Juan de Alicante, Alicante, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "D\u00edaz", 
        "givenName": "N.", 
        "id": "sg:person.01250234157.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250234157.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Catal\u00e0 d'Oncologia", 
          "id": "https://www.grid.ac/institutes/grid.418701.b", 
          "name": [
            "Department of Medical Oncology, Institut Catal\u00e0 d\u2019Oncologia, Girona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "del Barco", 
        "givenName": "S.", 
        "id": "sg:person.01154113067.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154113067.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital de Sant Pau", 
          "id": "https://www.grid.ac/institutes/grid.413396.a", 
          "name": [
            "Department of Medical Oncology, University Hospital Sant Pau, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barnadas", 
        "givenName": "A.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Catal\u00e0 d'Oncologia", 
          "id": "https://www.grid.ac/institutes/grid.418701.b", 
          "name": [
            "Department of Medical Oncology, Institut Catal\u00e0 d\u2019Oncologia, Badalona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Margel\u00ed", 
        "givenName": "M.", 
        "id": "sg:person.01164262534.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164262534.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Virgen de la Salud", 
          "id": "https://www.grid.ac/institutes/grid.413514.6", 
          "name": [
            "Department of Medical Oncology, Virgen de La Salud Hospital, Toledo, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garc\u00eda Carbonero", 
        "givenName": "I.", 
        "id": "sg:person.014530251075.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014530251075.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Arnau de Vilanova", 
          "id": "https://www.grid.ac/institutes/grid.413937.b", 
          "name": [
            "Department of Medical Oncology, Arnau de Vilanova Hospital, Valencia, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Llombart", 
        "givenName": "A.", 
        "id": "sg:person.0751130170.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751130170.59"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00280-013-2216-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007143918", 
          "https://doi.org/10.1007/s00280-013-2216-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000368330", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009036171"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-005-0092-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011359832", 
          "https://doi.org/10.1007/s00280-005-0092-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-005-0092-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011359832", 
          "https://doi.org/10.1007/s00280-005-0092-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1359-6349(04)90882-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014849367"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2010.122", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020678868", 
          "https://doi.org/10.1038/nrclinonc.2010.122"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2010.122", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020678868", 
          "https://doi.org/10.1038/nrclinonc.2010.122"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdj130", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023344808"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-016-3027-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024172599", 
          "https://doi.org/10.1007/s00280-016-3027-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.30.8213", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027184622"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/03007995.2016.1211518", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031139364"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/92.3.205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032301848"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.thorsurg.2014.12.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032347522"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-016-4009-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032444625", 
          "https://doi.org/10.1007/s10549-016-4009-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-016-4009-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032444625", 
          "https://doi.org/10.1007/s10549-016-4009-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910460220", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035932577"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdq409", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040836146"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.lungcan.2008.02.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043745517"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ctrv.2011.05.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053480283"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1023/a:1013567022670", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056306237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.09.057", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1075210187"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079002503", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/oxfordjournals.annonc.a059019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082534282"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1993.11.7.1245", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082753144"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1996.14.8.2197", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082918702"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1997.15.1.110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083031469"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12032-017-0975-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085441054", 
          "https://doi.org/10.1007/s12032-017-0975-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12032-017-0975-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085441054", 
          "https://doi.org/10.1007/s12032-017-0975-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clbc.2017.05.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090278991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clbc.2017.05.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090278991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-017-4556-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092444842", 
          "https://doi.org/10.1007/s10549-017-4556-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jjco/hyx188", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1099890037"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/14656566.2018.1425680", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100427917"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/14656566.2018.1425680", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100427917"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "PURPOSE: To evaluate the efficacy and safety of oral weekly vinorelbine 60\u00a0mg/m2 for metastatic breast cancer (MBC) in patients previously treated with anthracyclines or taxanes in routine clinical practice.\nMATERIALS AND METHODS: Fifty-five patients were enrolled in a prospective multicentre study conducted in Spain. Women\u2009\u2265\u200918\u00a0years of age with locally advanced breast cancer who were not candidates for surgical treatment with a radical intention or patients with stage IV disease, and who had received a prior taxane or anthracycline regimen were eligible for participation.\nRESULTS: Median age was 67\u00a0years. Median progression-free survival was 3.7\u00a0months (95% CI 2.5-4.9), median overall survival 10\u00a0months (95% CI 6.6-13.5), and overall response rate and clinical benefit rate were 29.1% and 49.1%, respectively. Main grade 3 and 4 toxicities were neutropenia 9.1%, febrile neutropenia 3.6% and constipation 3.6%. In total, 86% of the patients received complete treatment without delays or dose reduction. Moreover, HER2-positive patients who received oral vinorelbine concomitantly with trastuzumab showed better response (complete response: HER2-positive 14.3% vs. HER2-negative 0%; partial response: HER2-positive 42.9% vs. HER2-negative 25.6%; p\u2009=\u20090.008), better disease control rate (HER2-positive 100% vs. HER2-negative 46.2%; p\u2009=\u20090.011), and better values for the remaining analysed variables than HER2-negative patients.\nCONCLUSION: Our study provides real-world data on the use of oral weekly vinorelbine, which proves an effective and well-tolerated regimen for MBC patients previously treated with taxanes or anthracyclines. Patients with HER2-positive disease could also benefit from this treatment in combination with trastuzumab.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12094-018-1946-9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1035367", 
        "issn": [
          "1699-048X", 
          "1699-3055"
        ], 
        "name": "Clinical and Translational Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "21"
      }
    ], 
    "name": "Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens", 
    "pagination": "459-466", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "8ec058ea2b01b4d79a40db8bfa32ec3a3717954dd62b059dd4f91c0f4b9fe530"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30293232"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101247119"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12094-018-1946-9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1107436870"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12094-018-1946-9", 
      "https://app.dimensions.ai/details/publication/pub.1107436870"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000368_0000000368/records_78968_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs12094-018-1946-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12094-018-1946-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12094-018-1946-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12094-018-1946-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12094-018-1946-9'


 

This table displays all metadata directly associated to this object as RDF triples.

252 TRIPLES      21 PREDICATES      57 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12094-018-1946-9 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N716955fb39f24955a8037e00c7887174
4 schema:citation sg:pub.10.1007/s00280-005-0092-6
5 sg:pub.10.1007/s00280-013-2216-8
6 sg:pub.10.1007/s00280-016-3027-5
7 sg:pub.10.1007/s10549-016-4009-3
8 sg:pub.10.1007/s10549-017-4556-2
9 sg:pub.10.1007/s12032-017-0975-5
10 sg:pub.10.1038/nrclinonc.2010.122
11 https://app.dimensions.ai/details/publication/pub.1079002503
12 https://doi.org/10.1002/ijc.2910460220
13 https://doi.org/10.1016/j.clbc.2017.05.012
14 https://doi.org/10.1016/j.ctrv.2011.05.005
15 https://doi.org/10.1016/j.lungcan.2008.02.009
16 https://doi.org/10.1016/j.thorsurg.2014.12.003
17 https://doi.org/10.1016/s1359-6349(04)90882-8
18 https://doi.org/10.1023/a:1013567022670
19 https://doi.org/10.1080/03007995.2016.1211518
20 https://doi.org/10.1080/14656566.2018.1425680
21 https://doi.org/10.1093/annonc/mdj130
22 https://doi.org/10.1093/annonc/mdq409
23 https://doi.org/10.1093/jjco/hyx188
24 https://doi.org/10.1093/jnci/92.3.205
25 https://doi.org/10.1093/oxfordjournals.annonc.a059019
26 https://doi.org/10.1159/000368330
27 https://doi.org/10.1200/jco.1993.11.7.1245
28 https://doi.org/10.1200/jco.1996.14.8.2197
29 https://doi.org/10.1200/jco.1997.15.1.110
30 https://doi.org/10.1200/jco.2003.09.057
31 https://doi.org/10.1200/jco.2010.30.8213
32 schema:datePublished 2019-04
33 schema:datePublishedReg 2019-04-01
34 schema:description PURPOSE: To evaluate the efficacy and safety of oral weekly vinorelbine 60 mg/m2 for metastatic breast cancer (MBC) in patients previously treated with anthracyclines or taxanes in routine clinical practice. MATERIALS AND METHODS: Fifty-five patients were enrolled in a prospective multicentre study conducted in Spain. Women ≥ 18 years of age with locally advanced breast cancer who were not candidates for surgical treatment with a radical intention or patients with stage IV disease, and who had received a prior taxane or anthracycline regimen were eligible for participation. RESULTS: Median age was 67 years. Median progression-free survival was 3.7 months (95% CI 2.5-4.9), median overall survival 10 months (95% CI 6.6-13.5), and overall response rate and clinical benefit rate were 29.1% and 49.1%, respectively. Main grade 3 and 4 toxicities were neutropenia 9.1%, febrile neutropenia 3.6% and constipation 3.6%. In total, 86% of the patients received complete treatment without delays or dose reduction. Moreover, HER2-positive patients who received oral vinorelbine concomitantly with trastuzumab showed better response (complete response: HER2-positive 14.3% vs. HER2-negative 0%; partial response: HER2-positive 42.9% vs. HER2-negative 25.6%; p = 0.008), better disease control rate (HER2-positive 100% vs. HER2-negative 46.2%; p = 0.011), and better values for the remaining analysed variables than HER2-negative patients. CONCLUSION: Our study provides real-world data on the use of oral weekly vinorelbine, which proves an effective and well-tolerated regimen for MBC patients previously treated with taxanes or anthracyclines. Patients with HER2-positive disease could also benefit from this treatment in combination with trastuzumab.
35 schema:genre research_article
36 schema:inLanguage en
37 schema:isAccessibleForFree false
38 schema:isPartOf N50e2a6636caa473f828c403d61449bfd
39 N9e1bfd3848a141e4a396b76387fb0908
40 sg:journal.1035367
41 schema:name Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens
42 schema:pagination 459-466
43 schema:productId N0d0129b362ec4d8ea7289ffc34a1dd04
44 N2a027086f8cd48469bebeca388b9daa2
45 N2edb66ed81e943429160e675e5795df2
46 N8b606dbc280448f08ac00a14c5b46317
47 Nb911a89f035a420cb6e493998907f8b5
48 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107436870
49 https://doi.org/10.1007/s12094-018-1946-9
50 schema:sdDatePublished 2019-04-11T13:20
51 schema:sdLicense https://scigraph.springernature.com/explorer/license/
52 schema:sdPublisher N70e26818ed334a2f8fff095e12063912
53 schema:url https://link.springer.com/10.1007%2Fs12094-018-1946-9
54 sgo:license sg:explorer/license/
55 sgo:sdDataset articles
56 rdf:type schema:ScholarlyArticle
57 N03b8486175294716a10d42ee4f5d68a7 rdf:first N64d82c17488340fab3bf92b81fc29710
58 rdf:rest Nab057809e26e4b6f85026dca80bfa6e5
59 N0d0129b362ec4d8ea7289ffc34a1dd04 schema:name pubmed_id
60 schema:value 30293232
61 rdf:type schema:PropertyValue
62 N0f3a005724e645deb411bb27f84cd315 rdf:first sg:person.01152225642.04
63 rdf:rest N45c253ef9b8d4336a7ffe3921e003b70
64 N28aee821ecba4150ac9177e6c7ae1067 rdf:first sg:person.01132141013.48
65 rdf:rest N0f3a005724e645deb411bb27f84cd315
66 N2a027086f8cd48469bebeca388b9daa2 schema:name nlm_unique_id
67 schema:value 101247119
68 rdf:type schema:PropertyValue
69 N2edb66ed81e943429160e675e5795df2 schema:name doi
70 schema:value 10.1007/s12094-018-1946-9
71 rdf:type schema:PropertyValue
72 N3d6fa60a470f4599a0a642bc28dd7cc6 rdf:first sg:person.01154113067.83
73 rdf:rest N03b8486175294716a10d42ee4f5d68a7
74 N45c253ef9b8d4336a7ffe3921e003b70 rdf:first sg:person.012652353747.76
75 rdf:rest Nbc68316e43cd4113a04f899c6b7965e4
76 N50e2a6636caa473f828c403d61449bfd schema:volumeNumber 21
77 rdf:type schema:PublicationVolume
78 N56f068800ec34c10b40f7dc51b495186 rdf:first sg:person.014530251075.07
79 rdf:rest N82a50b1a1f7f44b784e0c9ccead7629e
80 N64d82c17488340fab3bf92b81fc29710 schema:affiliation https://www.grid.ac/institutes/grid.413396.a
81 schema:familyName Barnadas
82 schema:givenName A.
83 rdf:type schema:Person
84 N70e26818ed334a2f8fff095e12063912 schema:name Springer Nature - SN SciGraph project
85 rdf:type schema:Organization
86 N716955fb39f24955a8037e00c7887174 rdf:first sg:person.0651022236.90
87 rdf:rest N28aee821ecba4150ac9177e6c7ae1067
88 N82a50b1a1f7f44b784e0c9ccead7629e rdf:first sg:person.0751130170.59
89 rdf:rest rdf:nil
90 N8b606dbc280448f08ac00a14c5b46317 schema:name readcube_id
91 schema:value 8ec058ea2b01b4d79a40db8bfa32ec3a3717954dd62b059dd4f91c0f4b9fe530
92 rdf:type schema:PropertyValue
93 N9e1bfd3848a141e4a396b76387fb0908 schema:issueNumber 4
94 rdf:type schema:PublicationIssue
95 Nab057809e26e4b6f85026dca80bfa6e5 rdf:first sg:person.01164262534.28
96 rdf:rest N56f068800ec34c10b40f7dc51b495186
97 Nb1bc3903cf874ecaba473e8f00531e4d schema:name Department of Medical Oncology, University Hospital Arrixaca, Murcia, Spain
98 rdf:type schema:Organization
99 Nb911a89f035a420cb6e493998907f8b5 schema:name dimensions_id
100 schema:value pub.1107436870
101 rdf:type schema:PropertyValue
102 Nbc68316e43cd4113a04f899c6b7965e4 rdf:first sg:person.0603672146.43
103 rdf:rest Nd1732eec01094b71a1228ff645cc8b83
104 Nd1732eec01094b71a1228ff645cc8b83 rdf:first sg:person.01250234157.35
105 rdf:rest N3d6fa60a470f4599a0a642bc28dd7cc6
106 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
107 schema:name Medical and Health Sciences
108 rdf:type schema:DefinedTerm
109 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
110 schema:name Oncology and Carcinogenesis
111 rdf:type schema:DefinedTerm
112 sg:journal.1035367 schema:issn 1699-048X
113 1699-3055
114 schema:name Clinical and Translational Oncology
115 rdf:type schema:Periodical
116 sg:person.01132141013.48 schema:affiliation https://www.grid.ac/institutes/grid.411443.7
117 schema:familyName Aguirre
118 schema:givenName E.
119 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132141013.48
120 rdf:type schema:Person
121 sg:person.01152225642.04 schema:affiliation https://www.grid.ac/institutes/grid.411443.7
122 schema:familyName Morales
123 schema:givenName S.
124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152225642.04
125 rdf:type schema:Person
126 sg:person.01154113067.83 schema:affiliation https://www.grid.ac/institutes/grid.418701.b
127 schema:familyName del Barco
128 schema:givenName S.
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154113067.83
130 rdf:type schema:Person
131 sg:person.01164262534.28 schema:affiliation https://www.grid.ac/institutes/grid.418701.b
132 schema:familyName Margelí
133 schema:givenName M.
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164262534.28
135 rdf:type schema:Person
136 sg:person.01250234157.35 schema:affiliation https://www.grid.ac/institutes/grid.411263.3
137 schema:familyName Díaz
138 schema:givenName N.
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250234157.35
140 rdf:type schema:Person
141 sg:person.012652353747.76 schema:affiliation Nb1bc3903cf874ecaba473e8f00531e4d
142 schema:familyName Gonzálvez
143 schema:givenName M. L.
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012652353747.76
145 rdf:type schema:Person
146 sg:person.014530251075.07 schema:affiliation https://www.grid.ac/institutes/grid.413514.6
147 schema:familyName García Carbonero
148 schema:givenName I.
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014530251075.07
150 rdf:type schema:Person
151 sg:person.0603672146.43 schema:affiliation https://www.grid.ac/institutes/grid.411142.3
152 schema:familyName Servitja
153 schema:givenName S.
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603672146.43
155 rdf:type schema:Person
156 sg:person.0651022236.90 schema:affiliation https://www.grid.ac/institutes/grid.459499.c
157 schema:familyName Blancas
158 schema:givenName I.
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651022236.90
160 rdf:type schema:Person
161 sg:person.0751130170.59 schema:affiliation https://www.grid.ac/institutes/grid.413937.b
162 schema:familyName Llombart
163 schema:givenName A.
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751130170.59
165 rdf:type schema:Person
166 sg:pub.10.1007/s00280-005-0092-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011359832
167 https://doi.org/10.1007/s00280-005-0092-6
168 rdf:type schema:CreativeWork
169 sg:pub.10.1007/s00280-013-2216-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007143918
170 https://doi.org/10.1007/s00280-013-2216-8
171 rdf:type schema:CreativeWork
172 sg:pub.10.1007/s00280-016-3027-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024172599
173 https://doi.org/10.1007/s00280-016-3027-5
174 rdf:type schema:CreativeWork
175 sg:pub.10.1007/s10549-016-4009-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032444625
176 https://doi.org/10.1007/s10549-016-4009-3
177 rdf:type schema:CreativeWork
178 sg:pub.10.1007/s10549-017-4556-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092444842
179 https://doi.org/10.1007/s10549-017-4556-2
180 rdf:type schema:CreativeWork
181 sg:pub.10.1007/s12032-017-0975-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085441054
182 https://doi.org/10.1007/s12032-017-0975-5
183 rdf:type schema:CreativeWork
184 sg:pub.10.1038/nrclinonc.2010.122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020678868
185 https://doi.org/10.1038/nrclinonc.2010.122
186 rdf:type schema:CreativeWork
187 https://app.dimensions.ai/details/publication/pub.1079002503 schema:CreativeWork
188 https://doi.org/10.1002/ijc.2910460220 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035932577
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/j.clbc.2017.05.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090278991
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/j.ctrv.2011.05.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053480283
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/j.lungcan.2008.02.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043745517
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/j.thorsurg.2014.12.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032347522
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/s1359-6349(04)90882-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014849367
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1023/a:1013567022670 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056306237
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1080/03007995.2016.1211518 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031139364
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1080/14656566.2018.1425680 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100427917
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1093/annonc/mdj130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023344808
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1093/annonc/mdq409 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040836146
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1093/jjco/hyx188 schema:sameAs https://app.dimensions.ai/details/publication/pub.1099890037
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1093/jnci/92.3.205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032301848
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1093/oxfordjournals.annonc.a059019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082534282
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1159/000368330 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009036171
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1200/jco.1993.11.7.1245 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082753144
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1200/jco.1996.14.8.2197 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082918702
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1200/jco.1997.15.1.110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083031469
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1200/jco.2003.09.057 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075210187
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1200/jco.2010.30.8213 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027184622
227 rdf:type schema:CreativeWork
228 https://www.grid.ac/institutes/grid.411142.3 schema:alternateName Hospital Del Mar
229 schema:name Department of Medical Oncology, Hospital Del Mar, Barcelona, Spain
230 rdf:type schema:Organization
231 https://www.grid.ac/institutes/grid.411263.3 schema:alternateName Hospital Universitari Sant Joan D'Alacant
232 schema:name Department of Medical Oncology, University Hospital San Juan de Alicante, Alicante, Spain
233 rdf:type schema:Organization
234 https://www.grid.ac/institutes/grid.411443.7 schema:alternateName Hospital Universitari Arnau de Vilanova
235 schema:name Department of Medical Oncology, University Hospital Arnau de Vilanova, Lleida, Spain
236 rdf:type schema:Organization
237 https://www.grid.ac/institutes/grid.413396.a schema:alternateName Hospital de Sant Pau
238 schema:name Department of Medical Oncology, University Hospital Sant Pau, Barcelona, Spain
239 rdf:type schema:Organization
240 https://www.grid.ac/institutes/grid.413514.6 schema:alternateName Hospital Virgen de la Salud
241 schema:name Department of Medical Oncology, Virgen de La Salud Hospital, Toledo, Spain
242 rdf:type schema:Organization
243 https://www.grid.ac/institutes/grid.413937.b schema:alternateName Hospital Arnau de Vilanova
244 schema:name Department of Medical Oncology, Arnau de Vilanova Hospital, Valencia, Spain
245 rdf:type schema:Organization
246 https://www.grid.ac/institutes/grid.418701.b schema:alternateName Institut Català d'Oncologia
247 schema:name Department of Medical Oncology, Institut Català d’Oncologia, Badalona, Spain
248 Department of Medical Oncology, Institut Català d’Oncologia, Girona, Spain
249 rdf:type schema:Organization
250 https://www.grid.ac/institutes/grid.459499.c schema:alternateName Complejo Hospitalario Universitario de Granada
251 schema:name Department of Medical Oncology, University Hospital San Cecilio, Av. De la Investigación s/n, 18016, Granada, Spain
252 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...